{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:08:57Z","timestamp":1785344937619,"version":"3.55.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CE"],"DOI":"10.2147\/ce.s35675","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T03:33:08Z","timestamp":1380079988000},"page":"57","source":"Crossref","is-referenced-by-count":18,"title":["Sugammadex as a reversal agent for neuromuscular block: an evidence-based review"],"prefix":"10.2147","author":[{"given":"Heidrun","family":"Fink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,9]]},"container-title":["Core Evidence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=17595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:35:23Z","timestamp":1477866923000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/sugammadex-as-a-reversal-agent-for-neuromuscular-block-an-evidence-bas-peer-reviewed-article-CE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ce.s35675","relation":{},"ISSN":["1555-175X"],"issn-type":[{"value":"1555-175X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}